Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01153945

Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum

Association Between Cancer Cells and Normal Vs. Low Levels of Thyroid Hormones in the Serum

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Much experimental data has suggested that thyroid hormones (T3 and T4) may modulate neoplastic cells and that T3/T4 deprivation may remove this stimulus. It is now well established that T3/T4 affects cell division/angiogenesis through binding to integrin avb3, commonly over-expressed on many cancer cells. In the experimental settings, mimicking hypothyroidism in the cells is a difficult task. Currently, the use of charcoal stripped serum is used. Using this method, the serum is stripped not only from T3 and T4, as intended, but also from central and important cytokines and growth factor. This leads to a reduced rate of cancer cell proliferation and thus, does not reflect the natural environment in which cancer cells residue under hypothyroid conditions. The investigators aim to characterize and establish the effects of serum from hypothyroid patients on the proliferation/viability of a variety of cancer cell models.

Conditions

Timeline

Start date
2011-02-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-06-30
Last updated
2015-04-07

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01153945. Inclusion in this directory is not an endorsement.